|
Pyramid will develop a second-generation instrumentation for high-throughput brain-on-chip assays based on 3D-microstructured CMOS-based sensors, including a semi-automated data analysis software. All of which will empower pharmaceuticals to perform their pre-clinical compound screening.
|
